Nancy Cox Archives
Researchers develop framework for multiancestry genomic studies
Dec. 8, 2022—Vanderbilt researchers have developed a framework for the analysis of multiancestry, large-scale genomic studies across multiple biobanks.
NIH grant to address chronic diseases that affect populations with health disparities
Jan. 20, 2022—Vanderbilt University Medical Center, Meharry Medical College and the University of Miami Miller School of Medicine are the recipients of a $12.4 million grant from the National Institutes of Health to jointly develop the Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities.
NIH grant to address chronic diseases that affect populations with health disparities
Jan. 13, 2022—Vanderbilt University Medical Center, Meharry Medical College and the University of Miami Miller School of Medicine have received a major grant from the National Institutes of Health to jointly develop the Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities.
Study finds genetic risk factors for severe COVID-19 illness
Jul. 8, 2021—A massive worldwide collaboration including researchers from Vanderbilt University Medical Center (VUMC) has identified several genetic factors associated with SARS-CoV-2 infection and severe COVID-19 illness.
VUMC joins national effort to improve disease prediction in diverse populations
Jun. 16, 2021—Vanderbilt University Medical Center will participate in a new federal initiative aimed at improving the use of polygenic risk scores (PRS) to predict complex diseases in diverse populations.
EHRs, biobanks and Mendelian diseases
Apr. 30, 2020—Electronic health records and biobanks can be effectively combined to detect and study Mendelian diseases such as cystic fibrosis.
VUMC joins global effort to explore COVID-19 genetics
Apr. 23, 2020—Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19.
Vanderbilt-led team discovers new genetic disease and defines underlying mechanism
Jan. 13, 2020—An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms.
Study merges big data and zebrafish biology to reveal mechanisms of human disease
Apr. 24, 2019—In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease.
Researchers find high-risk genes for schizophrenia
Apr. 18, 2019—Using a unique computational framework they developed, a team of scientist cyber-sleuths in the Vanderbilt University Department of Molecular Physiology and Biophysics and the Vanderbilt Genetics Institute (VGI) has identified 104 high-risk genes for schizophrenia.
Precision Medicine meet
Jan. 10, 2019—Pictured at the recent 2018 Precision Medicine and Health Disparities Collaborative Annual Meeting are, from left, principal investigators Maria Lima, PhD (Meharry Medical College); Consuelo Wilkins, MD, MSCI (Meharry-Vanderbilt Alliance); Nancy Cox, PhD (Vanderbilt); and Roy Weiss, MD, PhD (University of Miami Miller School of Medicine).
Vanderbilt study links gene expression, disease association data
Jul. 26, 2018—An international team of researchers has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases.
